What does the evidence say about Black Seed Oil Sleep Onset Randomized Trial?

Updated August 2026

Quick Answer

Black Seed Oil Sleep Onset Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Staff from a UK higher education institution ( n = 28) with short sleep duration (<7 h) and elevated cardiometabolic risk were randomised to SEI or SI.

Key Takeaways

  • 01Staff from a UK higher education institution ( n = 28) with short sleep duration (<7 h) and elevated cardiometabolic risk were randomised to SEI or SI. [Du Preez A (2026)]
  • 02Workplaces offer a key setting for health improvement interventions, given their reach and potential to promote lasting behaviour change. [Du Preez A (2026)]
  • 03While diet and physical activity (PA) are common targets, sleep remains an underexplored yet influential factor in employee health. [Du Preez A (2026)]
  • 04These disturbances occur despite adequate opportunity and conditions for sleep [], and they result in general dissatisfaction with sleep quality and various daytime impairments. [&#379;e&#322;abowski Kacper (2025)]
The current Migaku evidence database contains 2 reusable source documents for Black Seed Oil Sleep Onset Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Staff from a UK higher education institution ( n = 28) with short sleep duration (<7 h) and elevated cardiometabolic risk were randomised to SEI or SI. [Du Preez A (2026); evidence level 2] - Workplaces offer a key setting for health improvement interventions, given their reach and potential to promote lasting behaviour change. [Du Preez A (2026); evidence level 2] - While diet and physical activity (PA) are common targets, sleep remains an underexplored yet influential factor in employee health. [Du Preez A (2026); evidence level 2] - These disturbances occur despite adequate opportunity and conditions for sleep [], and they result in general dissatisfaction with sleep quality and various daytime impairments. [&#379;e&#322;abowski Kacper (2025); evidence level 3] - Individuals reporting nighttime symptoms without associated daytime dysfunction are not classified as having clinical insomnia [,]. [&#379;e&#322;abowski Kacper (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Randomised feasibility trial of a remotely delivered holistic UK employee programme combining tailored sleep hygiene, diet, and physical activity counselling for weight management: a mixed-methods evaluation.
  2. The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs